SCHEMBL4599467

SCHEMBL4599467

COc1ccc(CNc2[c]ccc(F)c2)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.54
TSHR P16473 7/20 0.44
CYP1A2 P05177 6/20 0.44
CYP3A4 P08684 6/20 0.44
CYP2D6 P10635 6/20 0.44
CYP2C19 P33261 6/20 0.44
USP2 O75604 2/20 0.44
DHFR P00374 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPC1 O15118 1/20 0.44
PKM P14618 1/20 0.44
RAB9A P51151 1/20 0.44
TP53 P04637 1/20 0.44
ERBB2 P04626 1/20 0.43
PRKACA P17612 1/20 0.43
RPS6KB1 P23443 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
IRAK1 P51617 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599690 0.84 APLNR (0.54) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL4599436 0.84 APLNR (0.54) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL27972158 0.82 APLNR (0.54) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL4599593 0.81 MAP2K4 (0.52) MEN1KMT2ANPC1RAB9ATP53
SCHEMBL4599680 0.79 MAPT (0.52) APLNRCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL4600346 0.79 APLNR (0.48) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL12898531 0.79 APLNR (0.54) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL13898070 0.79 APLNR (0.54) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL4599421 0.77 MAOB (0.50) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL4610582 0.77 ALDH1A1 (0.45) APLNRTSHRCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed